van der Bent M, Evers M, Valles A
Biologics. 2022; 16:141-160.
PMID: 36213816
PMC: 9532260.
DOI: 10.2147/BTT.S270657.
Landrieu I, Dupre E, Sinnaeve D, El Hajjar L, Smet-Nocca C
Front Chem. 2022; 10:886382.
PMID: 35646824
PMC: 9133342.
DOI: 10.3389/fchem.2022.886382.
Sharma S, Young R, Chen J, Chen X, Oh E, Schiller M
Alzheimers Dement (N Y). 2018; 4:414-432.
PMID: 30225339
PMC: 6139474.
DOI: 10.1016/j.trci.2018.06.005.
Hwang S, Disatnik M, Mochly-Rosen D
EMBO Mol Med. 2015; 7(10):1307-26.
PMID: 26268247
PMC: 4604685.
DOI: 10.15252/emmm.201505256.
Tourette C, Li B, Bell R, OHare S, Kaltenbach L, Mooney S
J Biol Chem. 2014; 289(10):6709-6726.
PMID: 24407293
PMC: 3945331.
DOI: 10.1074/jbc.M113.523696.
Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.
Chua J, Lieberman A
CNS Neurol Disord Drug Targets. 2013; 12(8):1146-56.
PMID: 24040817
PMC: 4003563.
Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington's disease.
Landles C, Weiss A, Franklin S, Howland D, Bates G
PLoS Curr. 2012; 4:e4fd085bfc9973.
PMID: 22919566
PMC: 3423312.
DOI: 10.1371/4fd085bfc9973.
Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons.
Lejeune F, Mesrob L, Parmentier F, Bicep C, Vazquez-Manrique R, Parker J
BMC Genomics. 2012; 13:91.
PMID: 22413862
PMC: 3331833.
DOI: 10.1186/1471-2164-13-91.
Sp1 regulates human huntingtin gene expression.
Wang R, Luo Y, Ly P, Cai F, Zhou W, Zou H
J Mol Neurosci. 2012; 47(2):311-21.
PMID: 22399227
DOI: 10.1007/s12031-012-9739-z.
Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides.
Vitalis A, Pappu R
Biophys Chem. 2011; 159(1):14-23.
PMID: 21530061
PMC: 3166968.
DOI: 10.1016/j.bpc.2011.04.006.
Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin.
Ratovitski T, Chighladze E, Waldron E, Hirschhorn R, Ross C
J Biol Chem. 2011; 286(14):12578-89.
PMID: 21310951
PMC: 3069459.
DOI: 10.1074/jbc.M110.185348.
Downregulation of NF-kappaB signaling by mutant huntingtin proteins induces oxidative stress and cell death.
Reijonen S, Kukkonen J, Hyrskyluoto A, Kivinen J, Kairisalo M, Takei N
Cell Mol Life Sci. 2010; 67(11):1929-41.
PMID: 20232225
PMC: 11115952.
DOI: 10.1007/s00018-010-0305-y.
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.
Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S
J Biol Chem. 2010; 285(12):8808-23.
PMID: 20086007
PMC: 2838303.
DOI: 10.1074/jbc.M109.075028.
Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells.
Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, DAmbola J
J Biol Chem. 2009; 284(16):10855-67.
PMID: 19204007
PMC: 2667772.
DOI: 10.1074/jbc.M804813200.
Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization.
Vitalis A, Wang X, Pappu R
J Mol Biol. 2008; 384(1):279-97.
PMID: 18824003
PMC: 2847503.
DOI: 10.1016/j.jmb.2008.09.026.
Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.
Vosler P, Brennan C, Chen J
Mol Neurobiol. 2008; 38(1):78-100.
PMID: 18686046
PMC: 2726710.
DOI: 10.1007/s12035-008-8036-x.
A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
Colomer Gould V, Goti D, Pearce D, Gonzalez G, Gao H, de Leon M
Neurobiol Dis. 2007; 27(3):362-9.
PMID: 17632007
PMC: 2040168.
DOI: 10.1016/j.nbd.2007.06.005.
COPASAAR--a database for proteomic analysis of single amino acid repeats.
Depledge D, Dalby A
BMC Bioinformatics. 2005; 6:196.
PMID: 16078990
PMC: 1199582.
DOI: 10.1186/1471-2105-6-196.
The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.
Walsh R, Storey E, Stefani D, Kelly L, Turnbull V
Neurotox Res. 2005; 7(1-2):43-57.
PMID: 15639797
DOI: 10.1007/BF03033775.
A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
Goti D, Katzen S, Mez J, Kurtis N, Kiluk J, Ben-Haiem L
J Neurosci. 2004; 24(45):10266-79.
PMID: 15537899
PMC: 6730179.
DOI: 10.1523/JNEUROSCI.2734-04.2004.